Legislators Ask FDA To Rescind Kratom Advisory

kratom fda kratom advisory

Representative Dave Brat (R-VA) and Representative Jared Polis have penned a bipartisan Dear Colleague letter addressed to the Food and Drug Administration (FDA) in regards to the south east Asian plant, kratom. Kratom is a plant from the rubiacea family, making it a close botanical relative of coffee. It has been used safely for hundreds of years as a folk medicine in Indonesia and other south east Asian countries. In the past few years, however, it has become increasingly popular for use in the United States and elsewhere around the globe. The Dear Colleague letter addresses the FDA’s recent advisory of November, claiming kratom is dangerous, addictive, and could worsen the opioid epidemic.

Click here to continue and read more...

Share on Google Plus
    Blogger Comment
    Facebook Comment

0 comments :

Post a Comment